Randomized, double-blind pilot study on botulinum toxin type A in the treatment of axillary hidradenitis suppurativa؆
Jessica Shen Tsy Wu Kim, Kevin Yun Kim, Laís de Abreu Mutti, Fernanda de Carvalho Tironi, Anamaria da Silva Facina, Samira Yarak, Sergio Henrique Hirata · 2026
Read Randomized, double-blind pilot study on botulinum toxin type A in the treatment of axillary hidradenitis suppurativa؆ by Jessica Shen Tsy Wu Kim, Kevin Yun Kim, Laís de Abreu Mutti, Fernanda de Carvalho Tironi, Anamaria da Silva Facina, Samira Yarak, Sergio Henrique Hirata (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571480.txt.
Description
Jessica Shen Tsy Wu Kim and co-authors run a small blind trial in 2026 of toxin shots for a painful armpit skin disease. The disease brings sore lumps, pus pockets, and tunnels under the skin, and pain is the top drag on life quality. The toxin calms sweat glands and may cut the bursts that feed the disease for three to six months.
Each patient had both armpits in play for at least a year, with flares at least once a month. One side got the toxin in 25 small skin shots, and the other side got plain salt water, with no one told which was which. Checks ran at weeks 2, 12, and 24, with no other care in between. The design tests the shot as a low-harm choice for this hard disease.
Catalog record
| CREATOR | Jessica Shen Tsy Wu Kim, Kevin Yun Kim, Laís de Abreu Mutti, Fernanda de Carvalho Tironi, Anamaria da Silva Facina, Samira Yarak, Sergio Henrique Hirata |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |